EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access

High‐Dose Oral Omeprazole Versus Continuous Intravenous Pantoprazole in Patients With High‐Risk Peptic Ulcer Bleeding: A Single‐Blinded Multicenter RCT

Kanteera Sriyudthsak iD, Nutbordee Nalinthassanai, Bunyos Sriapiraksa, Pakkapon Rattanachaisit, Tanisa Patcharatrakul, Rapat Pittayanon

Journal of Gastroenterology and Hepatology · 2026

DOI: 10.1111/jgh.70566 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Kanteera Sriyudthsak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Re…. Hauptthemen laut MEDLINE: Omeprazole, Peptic Ulcer Hemorrhage, 2-Pyridinylmethylsulfinylbenzimidazoles, Anti-Ulcer Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The Gastroenterological Association of Thailand (GAT), Guardian Angel Thrift.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim The efficacy of high‐dose oral omeprazole in peptic ulcer bleeding after successful therapeutic hemostatic endoscopy has not been well established. This study aimed to compare the efficacy of high‐dose oral omeprazole versus continuous intravenous (IV) pantoprazole in rebleeding and percent time of gastric pH above 6.

Methods

Eligible patients were randomized with 1:1 concealed allocation to 40‐mg oral omeprazole twice daily or IV pantoprazole 8 mg/h for 72 h after index gastroscopy. Gastric pH was measured for 24 h during 48–72 h after starting the assigned medication. Rebleeding at 72 h and 30 days, as well as 24‐h gastric pH, were assessed.

Results

A total of 124 patients were analyzed. Seventy‐two‐hour rebleeding occurred in 1.6% (1/61) of the oral omeprazole group and 4.8% (3/63) of the IV pantoprazole group requiring endoscopic hemostasis (risk difference [RD] −3.1%, 95% CI −11.6% to 4.6%). Rebleeding within 30 days also showed no difference between groups (3.3% vs. 4.8%, RD −1.5%, 95% CI −10.1% to 7.0%). Gastric pH monitoring was completed in 48% (29/61) of the oral group and 41% (26/63) of the IV group. The median percentage of gastric pH > 6 was 56.3% (IQR 28.0%–92.0%) in the oral group and 27.3% (IQR 4.4%–77.7%) in the IV group ( p = 0.064).

Conclusions

High‐dose oral omeprazole may represent a feasible alternative to continuous IV pantoprazole in terms of preventing rebleeding at 72 h and 30 days and maintaining gastric pH > 6 among patients with peptic ulcer bleeding who underwent successful therapeutic hemostatic endoscopy. Trial Registration: Registration number: NCT04394663

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OmeprazolePeptic Ulcer Hemorrhage2-PyridinylmethylsulfinylbenzimidazolesAnti-Ulcer AgentsHumansPantoprazoleMaleFemaleAdministration, OralSingle-Blind MethodMiddle AgedRecurrenceTreatment OutcomeAgedHydrogen-Ion ConcentrationAdministration, IntravenousInfusions, IntravenousTime FactorsHemostasis, EndoscopicGastroscopyRisk

Stichwörter der Autor:innen

gastric pHintravenous pantoprazoleoral omeprazolepeptic ulcerrebleeding

Substanzen

OmeprazolePantoprazole2-PyridinylmethylsulfinylbenzimidazolesAnti-Ulcer Agents

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross, Bangkok, Thailand.
  • Division of Gastroenterology, Department of Medicine, Surin Hospital, Surin, Thailand.
  • Department of Medicine, Surin Hospital, Surin, Thailand.
  • Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Center of Excellence in Neurogastroenterology and Motility, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

ORCID-Profile: Kanteera Sriyudthsak

Förderung

  • The Gastroenterological Association of Thailand (GAT)
  • Guardian Angel Thrift

Zitieren

APA

Sriyudthsak, K., Nalinthassanai, N., Sriapiraksa, B., Rattanachaisit, P., Patcharatrakul, T., & Pittayanon, R. (2026). High‐Dose Oral Omeprazole Versus Continuous Intravenous Pantoprazole in Patients With High‐Risk Peptic Ulcer Bleeding: A Single‐Blinded Multicenter RCT. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70566

Vancouver

Sriyudthsak K, Nalinthassanai N, Sriapiraksa B, Rattanachaisit P, Patcharatrakul T, Pittayanon R. High‐Dose Oral Omeprazole Versus Continuous Intravenous Pantoprazole in Patients With High‐Risk Peptic Ulcer Bleeding: A Single‐Blinded Multicenter RCT. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70566

BibTeX
@article{Sriyudthsak2026,
  author = {Sriyudthsak, Kanteera and Nalinthassanai, Nutbordee and Sriapiraksa, Bunyos and Rattanachaisit, Pakkapon and Patcharatrakul, Tanisa and Pittayanon, Rapat},
  title = {High‐Dose Oral Omeprazole Versus Continuous Intravenous Pantoprazole in Patients With High‐Risk Peptic Ulcer Bleeding: A Single‐Blinded Multicenter RCT},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1111/jgh.70566}
}
Kostenlos starten →